Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
Cell
    April 2024
  1. WAYNE CJ, Blakney AK
    Self-amplifying RNA COVID-19 vaccine.
    Cell. 2024;187:1822-1822.
    >> Share

    February 2024
  2. QU P, Xu K, Faraone JN, Goodarzi N, et al
    Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
    Cell. 2024;187:585-595.
    >> Share

  3. ZHANG L, Kempf A, Nehlmeier I, Cossmann A, et al
    SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
    Cell. 2024;187:596-608.
    >> Share

    December 2023
  4. MATTESON NL, Hassler GW, Kurzban E, Schwab MA, et al
    Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics.
    Cell. 2023;186:5690-5704.
    >> Share

    November 2023
  5. MEIJERS M, Ruchnewitz D, Eberhardt J, Luksza M, et al
    Population immunity predicts evolutionary trajectories of SARS-CoV-2.
    Cell. 2023;186:5151-5164.
    >> Share

    October 2023
  6. SCHMIDT N, Ganskih S, Wei Y, Gabel A, et al
    SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.
    Cell. 2023;186:4834-4850.
    >> Share

  7. BOUHADDOU M, Reuschl AK, Polacco BJ, Thorne LG, et al
    SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
    Cell. 2023;186:4597-4614.
    >> Share

  8. WIMMERS F, Burrell AR, Feng Y, Zheng H, et al
    Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.
    Cell. 2023;186:4632-4651.
    >> Share

  9. WONG AC, Devason AS, Umana IC, Cox TO, et al
    Serotonin reduction in post-acute sequelae of viral infection.
    Cell. 2023 Oct 9:S0092-8674(23)01034-6. doi: 10.1016/j.cell.2023.
    >> Share

    September 2023
  10. HONCE R, Schultz-Cherry S
    Looking beyond the H5 avian influenza viruses.
    Cell. 2023;186:4003-4004.
    >> Share

    August 2023
  11. SAWITZKI B
    Haunting innate immune memories of COVID-19.
    Cell. 2023;186:3753-3755.
    >> Share

  12. CHEONG JG, Ravishankar A, Sharma S, Parkhurst CN, et al
    Epigenetic memory of coronavirus infection in innate immune cells and their progenitors.
    Cell. 2023;186:3882-3902.
    >> Share

  13. SUN H, Li H, Tong Q, Han Q, et al
    Airborne transmission of human-isolated avian H3N8 influenza virus between ferrets.
    Cell. 2023 Aug 24:S0092-8674(23)00891-7. doi: 10.1016/j.cell.2023.
    >> Share

  14. LACRAMPE A, Hu F
    Unveiling TMEM106B: SARS-CoV-2's secret entrance to the cell.
    Cell. 2023;186:3329-3331.
    >> Share

  15. BAGGEN J, Jacquemyn M, Persoons L, Vanstreels E, et al
    TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.
    Cell. 2023;186:3427-3442.
    >> Share

    July 2023
  16. FALSEY AR, Walsh EE
    Respiratory syncytial virus Prefusion F vaccine.
    Cell. 2023;186:3137-3137.
    >> Share

  17. TEGALLY H, Wilkinson E, Tsui JL, Moir M, et al
    Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern.
    Cell. 2023;186:3277-3290.
    >> Share

    May 2023
  18. ZOST SJ, Carnahan RH
    A budding new approach strengthens an important message.
    Cell. 2023;186:2283-2285.
    >> Share

  19. ARIETA CM, Xie YJ, Rothenberg DA, Diao H, et al
    The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection.
    Cell. 2023;186:2392-2409.
    >> Share

  20. HOFFMANN MAG, Yang Z, Huey-Tubman KE, Cohen AA, et al
    ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines.
    Cell. 2023;186:2380-2391.
    >> Share

  21. AHN M, Chen VC, Rozario P, Ng WL, et al
    Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases.
    Cell. 2023;186:2144-2159.
    >> Share

    March 2023
  22. OUDIT GY, Wang K, Viveiros A, Kellner MJ, et al
    Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic.
    Cell. 2023;186:906-922.
    >> Share

    February 2023
  23. NEIL SJD
    Pangolin merbecovirus gets down to (poly)basics.
    Cell. 2023;186:688-690.
    >> Share

  24. DADONAITE B, Crawford KHD, Radford CE, Farrell AG, et al
    A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike.
    Cell. 2023 Feb 13:S0092-8674(23)00103-4. doi: 10.1016/j.cell.2023.
    >> Share

  25. ROSAIN J, Neehus AL, Manry J, Yang R, et al
    Human IRF1 governs macrophagic IFN-gamma immunity to mycobacteria.
    Cell. 2023;186:621-645.
    >> Share

    January 2023
  26. WANG Q, Iketani S, Li Z, Liu L, et al
    Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.
    Cell. 2023;186:279-286.
    >> Share

  27. WU CT, Lidsky PV, Xiao Y, Cheng R, et al
    SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming.
    Cell. 2023;186:112-130.
    >> Share

  28. DE CARVALHO RVH, Ersching J, Barbulescu A, Hobbs A, et al
    Clonal replacement sustains long-lived germinal centers primed by respiratory viruses.
    Cell. 2023;186:131-146.
    >> Share

    December 2022
  29. BARTSCH YC, Cizmeci D, Kang J, Zohar T, et al
    Antibody effector functions are associated with protection from respiratory syncytial virus.
    Cell. 2022;185:4873-4886.
    >> Share

    November 2022
  30. YAN L, Huang Y, Ge J, Liu Z, et al
    A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.
    Cell. 2022;185:4347-4360.
    >> Share

  31. BUCKNER CM, Kardava L, El Merhebi O, Narpala SR, et al
    Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses.
    Cell. 2022;185:4333-4346.
    >> Share

  32. LE NOUEN C, Nelson CE, Liu X, Park HS, et al
    Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys.
    Cell. 2022 Nov 10:S0092-8674(22)01418-0. doi: 10.1016/j.cell.2022.
    >> Share

    October 2022
  33. PHILIPS RL, Wang Y, Cheon H, Kanno Y, et al
    The JAK-STAT pathway at 30: Much learned, much more to do.
    Cell. 2022;185:3857-3876.
    >> Share

  34. KIMURA I, Yamasoba D, Tamura T, Nao N, et al
    Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
    Cell. 2022;185:3992-4007.
    >> Share

  35. TAFT JM, Weber CR, Gao B, Ehling RA, et al
    Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain.
    Cell. 2022;185:4008-4022.
    >> Share

    September 2022
  36. ACHARYA D, Reis R, Volcic M, Liu G, et al
    Actin cytoskeleton remodeling primes RIG-I-like receptor activation.
    Cell. 2022;185:3588-3602.
    >> Share

  37. FRANK F, Keen MM, Rao A, Bassit L, et al
    Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.
    Cell. 2022;185:3603-3616.
    >> Share

  38. ROTHENBURG S, Yang Z, Beard P, Sawyer SL, et al
    Monkeypox emergency: Urgent questions and perspectives.
    Cell. 2022;185:3279-3281.
    >> Share

    August 2022
  39. CASANOVA JL, Abel L
    From rare disorders of immunity to common determinants of infection: Following the mechanistic thread.
    Cell. 2022;185:3086-3103.
    >> Share

  40. DOLTON G, Rius C, Hasan MS, Wall A, et al
    Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.
    Cell. 2022;185:2936-2951.
    >> Share

  41. LI L, Liao H, Meng Y, Li W, et al
    Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1.
    Cell. 2022;185:2952-2960.
    >> Share

    July 2022
  42. TUEKPRAKHON A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, et al
    Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
    Cell. 2022;185:2422-2433.
    >> Share

  43. KAO J, Frankland PW
    COVID fog demystified.
    Cell. 2022;185:2391-2393.
    >> Share

  44. FERNANDEZ-CASTANEDA A, Lu P, Geraghty AC, Song E, et al
    Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.
    Cell. 2022;185:2452-2468.
    >> Share

  45. ZHANG Z, Mateus J, Coelho CH, Dan JM, et al
    Humoral and cellular immune memory to four COVID-19 vaccines.
    Cell. 2022;185:2434-2451.
    >> Share

    June 2022
  46. XU K, Gao P, Liu S, Lu S, et al
    Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2.
    Cell. 2022;185:2265-2278.
    >> Share

  47. NUTALAI R, Zhou D, Tuekprakhon A, Ginn HM, et al
    Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
    Cell. 2022;185:2116-2131.
    >> Share

  48. YAMASOBA D, Kimura I, Nasser H, Morioka Y, et al
    Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
    Cell. 2022;185:2103-2115.
    >> Share

  49. CHATURVEDI S, Pablo M, Wolf M, Rosas-Rivera D, et al
    Disrupting autorepression circuitry generates "open-loop lethality" to yield escape-resistant antiviral agents.
    Cell. 2022;185:2086-2102.
    >> Share

    May 2022
  50. YEUNG ML, Teng JLL, Yuen KY
    Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity.
    Cell. 2022;185:1840-1841.
    >> Share

  51. BATLLE D, Monteil V, Garreta E, Hassler L, et al
    Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity.
    Cell. 2022;185:1837-1839.
    >> Share

  52. GOEL RR, Painter MM, Lundgreen KA, Apostolidis SA, et al
    Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine.
    Cell. 2022;185:1875-1887.
    >> Share

    April 2022
  53. YING B, Scheaffer SM, Whitener B, Liang CY, et al
    Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.
    Cell. 2022;185:1572-1587.
    >> Share

  54. GAGNE M, Moliva JI, Foulds KE, Andrew SF, et al
    mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron.
    Cell. 2022;185:1556-1571.
    >> Share

  55. SERVELLITA V, Syed AM, Morris MK, Brazer N, et al
    Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants.
    Cell. 2022;185:1539-1548.
    >> Share

  56. CHANDRASHEKAR A, Yu J, McMahan K, Jacob-Dolan C, et al
    Vaccine protection against the SARS-CoV-2 Omicron variant in macaques.
    Cell. 2022;185:1549-1555.
    >> Share

  57. RODDA LB, Morawski PA, Pruner KB, Fahning ML, et al
    Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.
    Cell. 2022;185:1588-1601.
    >> Share


  58. Bringing research to the intensive care setting.
    Cell. 2022;185:1275-1278.
    >> Share


  59. Learning lessons from lipids to make COVID-19 vaccines.
    Cell. 2022;185:1279-1282.
    >> Share

  60. LI C, Zhan W, Yang Z, Tu C, et al
    Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.
    Cell. 2022;185:1389-1401.
    >> Share

  61. YEN M, Ren J, Liu Q, Glassman CR, et al
    Facile discovery of surrogate cytokine agonists.
    Cell. 2022;185:1414-1430.
    >> Share

  62. QU L, Yi Z, Shen Y, Lin L, et al
    Circular RNA vaccines against SARS-CoV-2 and emerging variants.
    Cell. 2022 Apr 1. pii: S0092-8674(22)00394-4. doi: 10.1016/j.cell.2022.
    >> Share

    March 2022
  63. TANGYE SG, Burnett DL, Bull RA
    Getting to the (germinal) center of humoral immune responses to SARS-CoV-2.
    Cell. 2022;185:945-948.
    >> Share

  64. ZAZHYTSKA M, Kodra A, Hoagland DA, Frere J, et al
    Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia.
    Cell. 2022;185:1052-1064.
    >> Share

  65. ROLTGEN K, Nielsen SCA, Silva O, Younes SF, et al
    Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination.
    Cell. 2022;185:1025-1040.
    >> Share


  66. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
    Cell. 2022;185:916-938.
    >> Share

  67. SU Y, Yuan D, Chen DG, Ng RH, et al
    Multiple early factors anticipate post-acute COVID-19 sequelae.
    Cell. 2022;185:881-895.
    >> Share

  68. AFKHAMI S, D'Agostino MR, Zhang A, Stacey HD, et al
    Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
    Cell. 2022;185:896-915.
    >> Share

  69. TARKE A, Coelho CH, Zhang Z, Dan JM, et al
    SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.
    Cell. 2022;185:847-859.
    >> Share

  70. CUI Z, Liu P, Wang N, Wang L, et al
    Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.
    Cell. 2022;185:860-871.
    >> Share

    February 2022
  71. BORRIELLO F, Poli V, Shrock E, Spreafico R, et al
    An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity.
    Cell. 2022;185:614-629.
    >> Share

  72. MUDD PA, Minervina AA, Pogorelyy MV, Turner JS, et al
    SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans.
    Cell. 2022;185:603-613.
    >> Share

  73. WESEMANN DR
    Omicron's message on vaccines: Boosting begets breadth.
    Cell. 2022;185:411-413.
    >> Share

  74. SIDDLE KJ, Krasilnikova LA, Moreno GK, Schaffner SF, et al
    Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak.
    Cell. 2022;185:485-492.
    >> Share

  75. GEORG P, Astaburuaga-Garcia R, Bonaguro L, Brumhard S, et al
    Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
    Cell. 2022;185:493-512.
    >> Share

  76. HOFFMANN M, Kruger N, Schulz S, Cossmann A, et al
    The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.
    Cell. 2022;185:447-456.
    >> Share

  77. COLLINS F
    Francis Collins: Reflections on being the NIH Director.
    Cell. 2022;185:401-406.
    >> Share

    December 2021
  78. GRUBAUGH ND, Cobey S
    Of variants and vaccines.
    Cell. 2021;184:6222-6223.
    >> Share

  79. TERMINI CM, Rutaganira FUN, Palavicino-Maggio CB, Spriggs CC, et al
    Using virtual interviewing to create a more accessible hybrid academic job market.
    Cell. 2021;184:6217-6221.
    >> Share

  80. WENDISCH D, Dietrich O, Mari T, von Stillfried S, et al
    SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
    Cell. 2021;184:6243-6261.
    >> Share

  81. BUSHMAN M, Kahn R, Taylor BP, Lipsitch M, et al
    Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape.
    Cell. 2021;184:6229-6242.
    >> Share

  82. BRIAND SC, Cinelli M, Nguyen T, Lewis R, et al
    Infodemics: A new challenge for public health.
    Cell. 2021;184:6010-6014.
    >> Share

  83. XIAO Y, Lidsky PV, Shirogane Y, Aviner R, et al
    A defective viral genome strategy elicits broad protective immunity against respiratory viruses.
    Cell. 2021;184:6037-6051.
    >> Share

  84. CHATURVEDI S, Vasen G, Pablo M, Chen X, et al
    Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance.
    Cell. 2021;184:6022-6036.
    >> Share

    November 2021
  85. KHAN M, Yoo SJ, Clijsters M, Backaert W, et al
    Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb.
    Cell. 2021;184:5932-5949.
    >> Share

  86. KUMAR S, Javed R, Mudd M, Pallikkuth S, et al
    Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes.
    Cell. 2021;184:5950-5969.
    >> Share

  87. PAYNE RP, Longet S, Austin JA, Skelly DT, et al
    Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.
    Cell. 2021;184:5699-5714.
    >> Share

    October 2021
  88. CROSS G, Ho JSY, Zacharias W, Jeyasekharan AD, et al
    Emergency drug use in a pandemic: Harsh lessons from COVID-19.
    Cell. 2021;184:5497-5500.
    >> Share


  89. Persistent progress.
    Cell. 2021;184:5293-5296.
    >> Share

  90. SHAPIRO L, Losick R
    Delivering the message: How a novel technology enabled the rapid development of effective vaccines.
    Cell. 2021;184:5271-5274.
    >> Share

    September 2021
  91. MARTIN DP, Weaver S, Tegally H, San JE, et al
    The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages.
    Cell. 2021;184:5189-5200.
    >> Share

  92. CEVIK M, Grubaugh ND, Iwasaki A, Openshaw P, et al
    COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
    Cell. 2021;184:5077-5081.
    >> Share

  93. JACKSON B, Boni MF, Bull MJ, Colleran A, et al
    Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic.
    Cell. 2021;184:5179-5188.
    >> Share


  94. Building and supporting identity in peer review.
    Cell. 2021;184:5071-5072.
    >> Share

  95. ZELLER M, Gangavarapu K, Anderson C, Smither AR, et al
    Emergence of an early SARS-CoV-2 epidemic in the United States.
    Cell. 2021;184:4939-4952.
    >> Share

  96. SPOSITO B, Broggi A, Pandolfi L, Crotta S, et al
    The interferon landscape along the respiratory tract impacts the severity of COVID-19.
    Cell. 2021;184:4953-4968.
    >> Share

  97. HOLMES EC, Goldstein SA, Rasmussen AL, Robertson DL, et al
    The origins of SARS-CoV-2: A critical review.
    Cell. 2021;184:4848-4856.
    >> Share

  98. ZIEGLER CGK, Miao VN, Owings AH, Navia AW, et al
    Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
    Cell. 2021;184:4713-4733.
    >> Share

    August 2021
  99. KARLSSON EA, Duong V
    The continuing search for the origins of SARS-CoV-2.
    Cell. 2021;184:4373-4374.
    >> Share

  100. KANG L, He G, Sharp AK, Wang X, et al
    A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation.
    Cell. 2021;184:4392-4400.
    >> Share

  101. NATHAN A, Rossin EJ, Kaseke C, Park RJ, et al
    Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
    Cell. 2021;184:4401-4413.
    >> Share

  102. ZHOU H, Ji J, Chen X, Bi Y, et al
    Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses.
    Cell. 2021;184:4380-4391.
    >> Share

  103. LIU C, Ginn HM, Dejnirattisai W, Supasa P, et al
    Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
    Cell. 2021;184:4220-4236.
    >> Share

  104. LI D, Edwards RJ, Manne K, Martinez DR, et al
    In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
    Cell. 2021;184:4203-4219.
    >> Share

    July 2021
  105. RESCIGNO M
    Unraveling the long-term effect of influenza vaccines.
    Cell. 2021;184:3845-3847.
    >> Share

  106. WEINGARTEN-GABBAY S, Klaeger S, Sarkizova S, Pearlman LR, et al
    Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
    Cell. 2021;184:3962-3980.
    >> Share

  107. COPIN R, Baum A, Wloga E, Pascal KE, et al
    The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
    Cell. 2021;184:3949-3961.
    >> Share

    June 2021
  108. YAN L, Yang Y, Li M, Zhang Y, et al
    Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.
    Cell. 2021;184:3474-3485.
    >> Share

  109. LIU K, Pan X, Li L, Yu F, et al
    Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species.
    Cell. 2021;184:3438-3451.
    >> Share

  110. LIU Y, Soh WT, Kishikawa JI, Hirose M, et al
    An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
    Cell. 2021;184:3452-3466.
    >> Share

  111. HE X, Chandrashekar A, Zahn R, Wegmann F, et al
    Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
    Cell. 2021;184:3467-3473.
    >> Share

  112. HAO Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, et al
    Integrated analysis of multimodal single-cell data.
    Cell. 2021;184:3573-3587.
    >> Share

  113. DENG X, Garcia-Knight MA, Khalid MM, Servellita V, et al
    Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
    Cell. 2021;184:3426-3437.
    >> Share

  114. WIMMERS F, Donato M, Kuo A, Ashuach T, et al
    The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination.
    Cell. 2021 Jun 22. pii: S0092-8674(21)00692-9. doi: 10.1016/j.cell.2021.
    >> Share

  115. CORTI D, Purcell LA, Snell G, Veesler D, et al
    Tackling COVID-19 with neutralizing monoclonal antibodies.
    Cell. 2021;184:3086-3108.
    >> Share

  116. SCHEID JF, Barnes CO, Eraslan B, Hudak A, et al
    B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
    Cell. 2021;184:3205-3221.
    >> Share

  117. ASARNOW D, Wang B, Lee WH, Hu Y, et al
    Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
    Cell. 2021;184:3192-3204.
    >> Share

    May 2021
  118. BAUMER Y, Powell-Wiley TM
    Interdisciplinary approaches are fundamental to decode the biology of adversity.
    Cell. 2021;184:2797-2801.
    >> Share

  119. GARRETT ME, Galloway J, Chu HY, Itell HL, et al
    High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies.
    Cell. 2021;184:2927-2938.
    >> Share

  120. DEJNIRATTISAI W, Zhou D, Supasa P, Liu C, et al
    Antibody evasion by the P.1 strain of SARS-CoV-2.
    Cell. 2021;184:2939-2954.
    >> Share

  121. WILLIAMS WB, Meyerhoff RR, Edwards RJ, Li H, et al
    Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.
    Cell. 2021 May 18. pii: S0092-8674(21)00577-8. doi: 10.1016/j.cell.2021.
    >> Share

  122. ALPERT T, Brito AF, Lasek-Nesselquist E, Rothman J, et al
    Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.
    Cell. 2021;184:2595-2604.
    >> Share

  123. WASHINGTON NL, Gangavarapu K, Zeller M, Bolze A, et al
    Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
    Cell. 2021;184:2587-2594.
    >> Share

  124. HO JSY, Mok BW, Campisi L, Jordan T, et al
    TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
    Cell. 2021;184:2618-2632.
    >> Share

  125. CLARK SA, Clark LE, Pan J, Coscia A, et al
    SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.
    Cell. 2021;184:2605-2617.
    >> Share

  126. QIU X, Hanage WP, Taylor BP
    Coming to America: Genomic surveillance and how B.1.1.7 arrived in the US.
    Cell. 2021;184:2532-2534.
    >> Share

    April 2021
  127. LEBLANC EV, Colpitts CC
    SARS-CoV-2 RNA: Exclusive friends and common foes.
    Cell. 2021;184:2276-2278.
    >> Share

  128. BOEHM JS
    The power of parent scientists.
    Cell. 2021;184:2263-2270.
    >> Share

  129. HOFFMANN M, Arora P, Gross R, Seidel A, et al
    SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
    Cell. 2021;184:2384-2393.
    >> Share

  130. SURYADEVARA N, Shrihari S, Gilchuk P, VanBlargan LA, et al
    Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
    Cell. 2021;184:2316-2331.
    >> Share

  131. FABIUS JM, Krogan NJ
    Creating collaboration by breaking down scientific barriers.
    Cell. 2021;184:2271-2275.
    >> Share

  132. MCCALLUM M, De Marco A, Lempp FA, Tortorici MA, et al
    N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
    Cell. 2021;184:2332-2347.
    >> Share

  133. GARCIA-BELTRAN WF, Lam EC, St Denis K, Nitido AD, et al
    Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
    Cell. 2021;184:2372-2383.
    >> Share

  134. FLYNN RA, Belk JA, Qi Y, Yasumoto Y, et al
    Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.
    Cell. 2021;184:2394-2411.
    >> Share

  135. ZHOU D, Dejnirattisai W, Supasa P, Liu C, et al
    Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
    Cell. 2021;184:2348-2361.
    >> Share


  136. The origins of viral infection sleuth.
    Cell. 2021;184:1960-1961.
    >> Share

  137. SCHNEIDER JL, Rowe JH, Garcia-de-Alba C, Kim CF, et al
    The aging lung: Physiology, disease, and immunity.
    Cell. 2021;184:1990-2019.
    >> Share

  138. MILLS RJ, Humphrey SJ, Fortuna PRJ, Lor M, et al
    BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
    Cell. 2021;184:2167-2182.
    >> Share

  139. DEJNIRATTISAI W, Zhou D, Ginn HM, Duyvesteyn HME, et al
    The antigenic anatomy of SARS-CoV-2 receptor binding domain.
    Cell. 2021;184:2183-2200.
    >> Share

  140. SUPASA P, Zhou D, Dejnirattisai W, Liu C, et al
    Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
    Cell. 2021;184:2201-2211.
    >> Share

  141. YEUNG ML, Teng JLL, Jia L, Zhang C, et al
    Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.
    Cell. 2021;184:2212-2228.
    >> Share

  142. ZHANG X, Liu Y, Liu J, Bailey AL, et al
    A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
    Cell. 2021;184:2229-2238.
    >> Share

  143. PEIRIS JSM
    One world, one health.
    Cell. 2021;184:1956-1959.
    >> Share

  144. SCHULTZE JL, Aschenbrenner AC
    COVID-19 and the human innate immune system.
    Cell. 2021;184:1671-1692.
    >> Share

  145. YU B, Qi Y, Li R, Shi Q, et al
    B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells.
    Cell. 2021;184:1790-1803.
    >> Share

  146. LIU C, Martins AJ, Lau WW, Rachmaninoff N, et al
    Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
    Cell. 2021;184:1836-1857.
    >> Share

  147. WINKLER ES, Gilchuk P, Yu J, Bailey AL, et al
    Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
    Cell. 2021;184:1804-1820.
    >> Share

  148. ANDREANO E, Nicastri E, Paciello I, Pileri P, et al
    Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
    Cell. 2021;184:1821-1835.
    >> Share

  149. REN X, Wen W, Fan X, Hou W, et al
    COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
    Cell. 2021;184:1895-1913.
    >> Share

  150. SUN L, Li P, Ju X, Rao J, et al
    In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
    Cell. 2021;184:1865-1883.
    >> Share

  151. ANDERSON EM, Goodwin EC, Verma A, Arevalo CP, et al
    Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
    Cell. 2021;184:1858-1864.
    >> Share

    March 2021
  152. GEBRE MS, Brito LA, Tostanoski LH, Edwards DK, et al
    Novel approaches for vaccine development.
    Cell. 2021;184:1589-1603.
    >> Share

  153. SANDRONE S, Scott G, Anderson WJ, Musunuru K, et al
    Active learning-based STEM education for in-person and online learning.
    Cell. 2021;184:1409-1414.
    >> Share


  154. Scientific misinformation: A perfect storm, missteps, and moving forward.
    Cell. 2021;184:1402-1406.
    >> Share

  155. TOPOL EJ
    Messenger RNA vaccines against SARS-CoV-2.
    Cell. 2021;184:1401.
    >> Share

  156. PILLON NJ, Loos RJF, Marshall SM, Zierath JR, et al
    Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.
    Cell. 2021;184:1530-1544.
    >> Share

  157. MANN ME, Hall LJ, Dulvy NK
    Scientific impact in a changing world.
    Cell. 2021;184:1407-1408.
    >> Share

  158. THOMSON EC, Rosen LE, Shepherd JG, Spreafico R, et al
    Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
    Cell. 2021;184:1171-1187.
    >> Share

  159. GRUBAUGH ND, Hodcroft EB, Fauver JR, Phelan AL, et al
    Public health actions to control new SARS-CoV-2 variants.
    Cell. 2021;184:1127-1132.
    >> Share

  160. BROUWER PJM, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, et al
    Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.
    Cell. 2021;184:1188-1200.
    >> Share

  161. SOKAL A, Chappert P, Barba-Spaeth G, Roeser A, et al
    Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
    Cell. 2021;184:1201-1213.
    >> Share

    February 2021
  162. LI Q, Nie J, Wu J, Zhang L, et al
    SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
    Cell. 2021 Feb 23. pii: S0092-8674(21)00231-2. doi: 10.1016/j.cell.2021.
    >> Share

  163. SETTE A, Crotty S
    Adaptive immunity to SARS-CoV-2 and COVID-19.
    Cell. 2021;184:861-880.
    >> Share

  164. NIE X, Qian L, Sun R, Huang B, et al
    Multi-organ proteomic landscape of COVID-19 autopsies.
    Cell. 2021;184:775-791.
    >> Share

  165. ATYEO C, Pullen KM, Bordt EA, Fischinger S, et al
    Compromised SARS-CoV-2-specific placental antibody transfer.
    Cell. 2021;184:628-642.
    >> Share

    January 2021
  166. GARCIA-BELTRAN WF, Lam EC, Astudillo MG, Yang D, et al
    COVID-19-neutralizing antibodies predict disease severity and survival.
    Cell. 2021;184:476-488.
    >> Share

  167. HOANG TN, Pino M, Boddapati AK, Viox EG, et al
    Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
    Cell. 2021;184:460-475.
    >> Share


  168. What happens next.
    Cell. 2021;184:291-292.
    >> Share

  169. HOFFMANN HH, Schneider WM, Rozen-Gagnon K, Miles LA, et al
    TMEM41B Is a Pan-flavivirus Host Factor.
    Cell. 2021;184:133-148.
    >> Share

  170. WANG R, Simoneau CR, Kulsuptrakul J, Bouhaddou M, et al
    Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
    Cell. 2021;184:106-119.
    >> Share

  171. RODDA LB, Netland J, Shehata L, Pruner KB, et al
    Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
    Cell. 2021;184:169-183.
    >> Share

  172. KARKI R, Sharma BR, Tuladhar S, Williams EP, et al
    Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Cell. 2021;184:149-168.
    >> Share

  173. VOLZ E, Hill V, McCrone JT, Price A, et al
    Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
    Cell. 2021;184:64-75.
    >> Share

  174. DANILOSKI Z, Jordan TX, Wessels HH, Hoagland DA, et al
    Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
    Cell. 2021;184:92-105.
    >> Share

  175. WEI J, Alfajaro MM, DeWeirdt PC, Hanna RE, et al
    Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
    Cell. 2021;184:76-91.
    >> Share

    December 2020
  176. AVANZATO VA, Matson MJ, Seifert SN, Pryce R, et al
    Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.
    Cell. 2020;183:1901-1912.
    >> Share

  177. ZOHAR T, Loos C, Fischinger S, Atyeo C, et al
    Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
    Cell. 2020;183:1508-1519.
    >> Share

  178. SU Y, Chen D, Yuan D, Lausted C, et al
    Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
    Cell. 2020;183:1479-1495.
    >> Share

  179. CHEN Y, Zuiani A, Fischinger S, Mullur J, et al
    Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
    Cell. 2020;183:1496-1507.
    >> Share

  180. GHOSH S, Dellibovi-Ragheb TA, Kerviel A, Pak E, et al
    beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
    Cell. 2020;183:1520-1535.
    >> Share

    November 2020
  181. WALLS AC, Fiala B, Schafer A, Wrenn S, et al
    Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
    Cell. 2020;183:1367-1382.
    >> Share

  182. MECKIFF BJ, Ramirez-Suastegui C, Fajardo V, Chee SJ, et al
    Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
    Cell. 2020;183:1340-1353.
    >> Share

  183. BANERJEE AK, Blanco MR, Bruce EA, Honson DD, et al
    SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
    Cell. 2020;183:1325-1339.
    >> Share

  184. AID M, Busman-Sahay K, Vidal SJ, Maliga Z, et al
    Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.
    Cell. 2020;183:1354-1366.
    >> Share

  185. KREYE J, Reincke SM, Kornau HC, Sanchez-Sendin E, et al
    A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
    Cell. 2020;183:1058-1069.
    >> Share

  186. LEIST SR, Dinnon KH 3rd, Schafer A, Tse LV, et al
    A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
    Cell. 2020;183:1070-1085.
    >> Share

  187. RYDYZNSKI MODERBACHER C, Ramirez SI, Dan JM, Grifoni A, et al
    Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
    Cell. 2020;183:996-1012.
    >> Share

  188. PICCOLI L, Park YJ, Tortorici MA, Czudnochowski N, et al
    Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
    Cell. 2020;183:1024-1042.
    >> Share

  189. GRUBER CN, Patel RS, Trachtman R, Lepow L, et al
    Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
    Cell. 2020;183:982-995.
    >> Share

  190. CLAUSEN TM, Sandoval DR, Spliid CB, Pihl J, et al
    SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
    Cell. 2020;183:1043-1057.
    >> Share

  191. CONSIGLIO CR, Cotugno N, Sardh F, Pou C, et al
    The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
    Cell. 2020;183:968-981.
    >> Share

    October 2020
  192. YURKOVETSKIY L, Wang X, Pascal KE, Tomkins-Tinch C, et al
    Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
    Cell. 2020;183:739-751.
    >> Share

  193. MUKHERJEE S
    Before Virus, After Virus: A Reckoning.
    Cell. 2020;183:308-314.
    >> Share

  194. IWASAKI A, Omer SB
    Why and How Vaccines Work.
    Cell. 2020;183:290-295.
    >> Share

  195. GOLDSTEIN JL
    The Spanish 1918 Flu and the COVID-19 Disease: The Art of Remembering and Foreshadowing Pandemics.
    Cell. 2020;183:285-289.
    >> Share

  196. LI W, Schafer A, Kulkarni SS, Liu X, et al
    High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models.
    Cell. 2020;183:429-441.
    >> Share

  197. SEKINE T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, et al
    Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
    Cell. 2020;183:158-168.
    >> Share

  198. AU L, Boos LA, Swerdlow A, Byrne F, et al
    Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.
    Cell. 2020;183:4-10.
    >> Share

  199. CANETE PF, Vinuesa CG
    COVID-19 Makes B Cells Forget, but T Cells Remember.
    Cell. 2020;183:13-15.
    >> Share

  200. HASSAN AO, Kafai NM, Dmitriev IP, Fox JM, et al
    A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
    Cell. 2020;183:169-184.
    >> Share

  201. IADECOLA C, Anrather J, Kamel H
    Effects of COVID-19 on the Nervous System.
    Cell. 2020;183:16-27.
    >> Share

  202. KANEKO N, Kuo HH, Boucau J, Farmer JR, et al
    Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
    Cell. 2020;183:143-157.
    >> Share

    September 2020
  203. COLUBRI A, Kemball M, Sani K, Boehm C, et al
    Preventing Outbreaks through Interactive, Experiential Real-Life Simulations.
    Cell. 2020;182:1366-1371.
    >> Share

  204. SCHULTE-SCHREPPING J, Reusch N, Paclik D, Bassler K, et al
    Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
    Cell. 2020;182:1419-1440.
    >> Share

  205. DU S, Cao Y, Zhu Q, Yu P, et al
    Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.
    Cell. 2020 Sep 14. pii: S0092-8674(20)31232-0. doi: 10.1016/j.cell.2020.
    >> Share

    August 2020
  206. GEITMANN A
    Travel Less. Make It Worthwhile.
    Cell. 2020;182:790-793.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016